Polpharma invests US $37 million in Kazakhstan
Leading Polish pharmaceutical group Polpharma has launched a US $37 million investment programme for its production facility in Shymkent, southern Kazakhstan.
The project will involve digitising the production processes, enhancing the level of automation, improving logistics and building a new laboratory.
The investments will enable the pharmaceutical company to meet five major long-term supply contracts signed with the Kazakh institutions.
(ITA Almaty)
